FDA Approves Combination Treatment for Lymphoma Subtype that has Returned or Worsened Thumbnail Image Read more about FDA Approves Combination Treatment for Lymphoma Subtype that has Returned or Worsened
Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types Thumbnail Image Read more about Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types
First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma Thumbnail Image Read more about First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma
FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer Thumbnail Image Read more about FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia Thumbnail Image Read more about FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
New Formulation of Important CML Drug Comes with No Mealtime Restrictions Thumbnail Image Read more about New Formulation of Important CML Drug Comes with No Mealtime Restrictions
Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype Thumbnail Image Read more about Oral Formulation of Methotrexate Now Available for Children with Leukemia Subtype
FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia Thumbnail Image Read more about FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia
FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia Thumbnail Image Read more about FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia
FDA Approves Targeted Therapy for Patients with Newly Diagnosed Multiple Myeloma Thumbnail Image Read more about FDA Approves Targeted Therapy for Patients with Newly Diagnosed Multiple Myeloma
